Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking.

McEvoy JP, Freudenreich O.

Evid Based Ment Health. 2011 May;14(2):53. doi: 10.1136/ebmh.14.2.53. No abstract available.

PMID:
21502159
2.

Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors.

Czyrak A, Jaros T, Moryl E, Maj J.

Pharmacopsychiatry. 1993 Mar;26(2):53-8.

PMID:
7690975
3.

Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study.

Meyer-Lindenberg A, Gruppe H, Bauer U, Lis S, Krieger S, Gallhofer B.

Pharmacopsychiatry. 1997 Mar;30(2):35-42.

PMID:
9131723
4.

An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.

Flynn SW, MacEwan GW, Altman S, Kopala LC, Fredrikson DH, Smith GN, Honer WG.

Pharmacopsychiatry. 1998 Jan;31(1):25-9.

PMID:
9524981
6.

Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

Lindenmayer JP, Iskander A, Park M, Apergi FS, Czobor P, Smith R, Allen D.

J Clin Psychiatry. 1998 Oct;59(10):521-7.

PMID:
9818633
7.

Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.

Lerma-Carrillo I, Molina JD, Cuevas-Durán T, González-Parra S, Blasco-Fontecilla H, Andrade-Rosa C, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2007 Mar-Apr;30(2):114-21. Review.

PMID:
17414944
8.

Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.

Czyrak A, Skuza G, Rogóz Z, Frankiewicz T, Maj J.

Arzneimittelforschung. 1994 Feb;44(2):113-8.

PMID:
7511901
9.

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.

J Clin Psychiatry. 2005 Jan;66(1):63-72.

PMID:
15669890
10.

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.

Klieser E, Lehmann E, Kinzler E, Wurthmann C, Heinrich K.

J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):45S-51S.

PMID:
7537287
11.

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.

Zink M, Kuwilsky A, Krumm B, Dressing H.

J Psychopharmacol. 2009 May;23(3):305-14. doi: 10.1177/0269881108089593. Epub 2008 Jun 18.

PMID:
18562423
12.

Clozapine and risperidone: refining and extending their use.

Buckley PF, Schulz SC.

Harv Rev Psychiatry. 1996 Nov-Dec;4(4):184-99. Review.

PMID:
9384993
13.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
14.

Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.

Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG.

J Clin Psychiatry. 1998 Apr;59(4):184-8.

PMID:
9590669
15.

Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.

Okamura N, Hashimoto K, Kanahara N, Shimizu E, Kumakiri C, Komatsu N, Iyo M.

Eur J Pharmacol. 2003 Feb 14;461(2-3):93-8.

PMID:
12586203
16.

Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.

Chouinard G, Vainer JL, Bélanger MC, Turnier L, Beaudry P, Roy JY, Miller R.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Nov;18(7):1129-41.

PMID:
7531355
17.

Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study.

Wahlbeck K, Cheine M, Tuisku K, Ahokas A, Joffe G, Rimón R.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):911-22.

PMID:
11041534
18.

Clozapine alone versus clozapine and risperidone with refractory schizophrenia.

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R; Clozapine and Risperidone Enhancement (CARE) Study Group.

N Engl J Med. 2006 Feb 2;354(5):472-82.

19.

Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.

Kim JH, Kim D, Marder SR.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):984-8. doi: 10.1016/j.pnpbp.2008.01.009. Epub 2008 Jan 18.

PMID:
18262321
20.

Risperidone and clozapine combination for the treatment of refractory schizophrenia.

Morera AL, Barreiro P, Cano-Muñoz JL.

Acta Psychiatr Scand. 1999 Apr;99(4):305-6; discussion 306-7.

PMID:
10223435

Supplemental Content

Support Center